Cohen Capital Management buys $10,245,444 stake in Zimmer Biomet Holdings Inc (ZBH)

Zimmer Biomet Holdings Inc (ZBH) : Cohen Capital Management scooped up 1,750 additional shares in Zimmer Biomet Holdings Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 13, 2016. The investment management firm now holds a total of 80,730 shares of Zimmer Biomet Holdings Inc which is valued at $10,245,444.Zimmer Biomet Holdings Inc makes up approximately 3.07% of Cohen Capital Management’s portfolio.

Other Hedge Funds, Including , Pensionfund Sabic added ZBH to its portfolio by purchasing 15,000 company shares during the most recent quarter which is valued at $1,899,300. Zimmer Biomet Holdings Inc makes up approx 0.59% of Pensionfund Sabic’s portfolio.Atria Investments reduced its stake in ZBH by selling 272 shares or 14.04% in the most recent quarter. The Hedge Fund company now holds 1,665 shares of ZBH which is valued at $210,822. Zimmer Biomet Holdings Inc makes up approx 0.02% of Atria Investments’s portfolio.Exxonmobil Investment Management Inc Tx reduced its stake in ZBH by selling 503 shares or 0.98% in the most recent quarter. The Hedge Fund company now holds 51,070 shares of ZBH which is valued at $6,690,170. Zimmer Biomet Holdings Inc makes up approx 0.14% of Exxonmobil Investment Management Inc Tx’s portfolio.

Zimmer Biomet Holdings Inc closed down -6.12 points or -4.61% at $126.62 with 21,82,265 shares getting traded on Tuesday. Post opening the session at $132.31, the shares hit an intraday low of $125.57 and an intraday high of $132.31 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Zimmer Biomet Holdings Inc reported $2.02 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $1.97. The company had revenue of $1934.00 million for the quarter, compared to analysts expectations of $1898.18 million. The company’s revenue was up 65.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.58 EPS.

Many Wall Street Analysts have commented on Zimmer Biomet Holdings Inc. SunTrust Initiated Zimmer Biomet Holdings Inc on Aug 11, 2016 to “Buy”, Price Target of the shares are set at $155.Company shares were Reiterated by Needham on Jul 29, 2016 to “Buy”, Firm has raised the Price Target to $ 150 from a previous price target of $143 .Company shares were Reiterated by Needham on Jul 18, 2016 to “Buy”, Firm has raised the Price Target to $ 143 from a previous price target of $134 .

Zimmer Biomet Holdings Inc. formerly Zimmer Holdings Inc. is a musculoskeletal healthcare company. The Company designs manufactures and markets orthopedic reconstructive products; sports medicine biologics extremities and trauma products; spine bone healing craniomaxillofacial and thoracic products; dental implants and related surgical products. The Company manages its operations through three geographic segments: the Americas comprising principally of the United States and includes other North Central and South American markets; Europe comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers and directly to dental practices and dental laboratories.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Zimmer Biomet Holdings Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Zimmer Biomet Holdings Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.